Strategy

Antisense Pharma develops innovative drugs based on the antisense technology for targeted treatment of aggressive tumors, for which there is a very high unmet medical need.

Such tumors include pancreatic cancer, malignant melanoma (skin cancer), and other solid tumors.

Antisense Pharma pursues an immunotherapeutic strategy with a potentially long-lasting effect against malignant tumor diseases.

Antisense Pharma covers a wide spectrum of drug development, beginning with the discovery and patenting of suitable drug candidates, to their preclinical and clinical development.